 | • レポートコード：QAF27476 • 出版社/出版日：QYResearch / 2021年4月16日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の治療用核医学市場について種類別（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別（甲状腺、骨転移、リンパ腫、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・治療用核医学市場の概要 ・世界の主要地域別治療用核医学市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の治療用核医学市場規模2016-2021：種類別（ラジウム-223、ルテチウム-177、ヨウ素-131、その他） ・世界の治療用核医学市場予測2012-2027：種類別（ラジウム-223、ルテチウム-177、ヨウ素-131、その他） ・世界の治療用核医学市場規模2016-2021：用途別（甲状腺、骨転移、リンパ腫、その他） ・世界の治療用核医学市場予測2012-2027：用途別（甲状腺、骨転移、リンパ腫、その他） ・治療用核医学のアメリカ市場規模と予測2016-2021 ・治療用核医学のヨーロッパ市場規模と予測2016-2021 ・治療用核医学の中国市場規模と予測2016-2021 ・治療用核医学の日本市場規模と予測2016-2021 ・治療用核医学の東南アジア市場規模と予測2016-2021 ・治療用核医学のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novartis AG、Bayer、China Isotope & Radiation、Q BioMed、Curium Pharmaceuticals、Jubilant DraxImage、Dongcheng、Lantheus、Acrotech Biopharma.、Progenics Pharmaceuticals、International Isotopes） ・治療用核医学の製造コスト分析 ・販売チャネル、流通業者、顧客 ・治療用核医学の市場動向・機会・課題 ・調査の結論 |
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Market Analysis and Insights: Global Therapeutic Nuclear Medicines Market
The global Therapeutic Nuclear Medicines market was valued at US$ 1296.2 in 2020 and will reach US$ 2815.3 million by the end of 2027, growing at a CAGR of 13.8% during 2022-2027.
Global Therapeutic Nuclear Medicines Scope and Market Size
The global Therapeutic Nuclear Medicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Nuclear Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
The Therapeutic Nuclear Medicines market is analysed and market size information is provided by regions (countries). Segment by Application, the Therapeutic Nuclear Medicines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
1 Therapeutic Nuclear Medicines Market Overview
1.1 Therapeutic Nuclear Medicines Product Scope
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Sales by Type (2016 & 2021 & 2027)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Global Therapeutic Nuclear Medicines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Therapeutic Nuclear Medicines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Therapeutic Nuclear Medicines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Therapeutic Nuclear Medicines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Therapeutic Nuclear Medicines Price Trends (2016-2027)
2 Therapeutic Nuclear Medicines Estimates and Forecasts by Region
2.1 Global Therapeutic Nuclear Medicines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Therapeutic Nuclear Medicines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2021)
2.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2016-2021)
2.3 Global Therapeutic Nuclear Medicines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Therapeutic Nuclear Medicines Estimates and Projections (2016-2027)
2.4.2 Europe Therapeutic Nuclear Medicines Estimates and Projections (2016-2027)
2.4.3 China Therapeutic Nuclear Medicines Estimates and Projections (2016-2027)
2.4.4 Japan Therapeutic Nuclear Medicines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Therapeutic Nuclear Medicines Estimates and Projections (2016-2027)
2.4.6 India Therapeutic Nuclear Medicines Estimates and Projections (2016-2027)
3 Global Therapeutic Nuclear Medicines Competition Landscape by Players
3.1 Global Top Therapeutic Nuclear Medicines Players by Sales (2016-2021)
3.2 Global Top Therapeutic Nuclear Medicines Players by Revenue (2016-2021)
3.3 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Nuclear Medicines as of 2020)
3.4 Global Therapeutic Nuclear Medicines Average Price by Company (2016-2021)
3.5 Manufacturers Therapeutic Nuclear Medicines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Therapeutic Nuclear Medicines Market Size by Type
4.1 Global Therapeutic Nuclear Medicines Historic Market Review by Type (2016-2021)
4.1.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
4.1.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2016-2021)
4.1.3 Global Therapeutic Nuclear Medicines Price by Type (2016-2021)
4.2 Global Therapeutic Nuclear Medicines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2022-2027)
4.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2022-2027)
4.2.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2022-2027)
5 Global Therapeutic Nuclear Medicines Market Size by Application
5.1 Global Therapeutic Nuclear Medicines Historic Market Review by Application (2016-2021)
5.1.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
5.1.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2016-2021)
5.1.3 Global Therapeutic Nuclear Medicines Price by Application (2016-2021)
5.2 Global Therapeutic Nuclear Medicines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2022-2027)
5.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2022-2027)
5.2.3 Global Therapeutic Nuclear Medicines Price Forecast by Application (2022-2027)
6 North America Therapeutic Nuclear Medicines Market Facts & Figures
6.1 North America Therapeutic Nuclear Medicines Sales by Company
6.1.1 North America Therapeutic Nuclear Medicines Sales by Company (2016-2021)
6.1.2 North America Therapeutic Nuclear Medicines Revenue by Company (2016-2021)
6.2 North America Therapeutic Nuclear Medicines Sales Breakdown by Type
6.2.1 North America Therapeutic Nuclear Medicines Sales Breakdown by Type (2016-2021)
6.2.2 North America Therapeutic Nuclear Medicines Sales Breakdown by Type (2022-2027)
6.3 North America Therapeutic Nuclear Medicines Sales Breakdown by Application
6.3.1 North America Therapeutic Nuclear Medicines Sales Breakdown by Application (2016-2021)
6.3.2 North America Therapeutic Nuclear Medicines Sales Breakdown by Application (2022-2027)
7 Europe Therapeutic Nuclear Medicines Market Facts & Figures
7.1 Europe Therapeutic Nuclear Medicines Sales by Company
7.1.1 Europe Therapeutic Nuclear Medicines Sales by Company (2016-2021)
7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Company (2016-2021)
7.2 Europe Therapeutic Nuclear Medicines Sales Breakdown by Type
7.2.1 Europe Therapeutic Nuclear Medicines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Therapeutic Nuclear Medicines Sales Breakdown by Type (2022-2027)
7.3 Europe Therapeutic Nuclear Medicines Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Therapeutic Nuclear Medicines Market Facts & Figures
8.1 China Therapeutic Nuclear Medicines Sales by Company
8.1.1 China Therapeutic Nuclear Medicines Sales by Company (2016-2021)
8.1.2 China Therapeutic Nuclear Medicines Revenue by Company (2016-2021)
8.2 China Therapeutic Nuclear Medicines Sales Breakdown by Type
8.2.1 China Therapeutic Nuclear Medicines Sales Breakdown by Type (2016-2021)
8.2.2 China Therapeutic Nuclear Medicines Sales Breakdown by Type (2022-2027)
8.3 China Therapeutic Nuclear Medicines Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Therapeutic Nuclear Medicines Market Facts & Figures
9.1 Japan Therapeutic Nuclear Medicines Sales by Company
9.1.1 Japan Therapeutic Nuclear Medicines Sales by Company (2016-2021)
9.1.2 Japan Therapeutic Nuclear Medicines Revenue by Company (2016-2021)
9.2 Japan Therapeutic Nuclear Medicines Sales Breakdown by Type
9.2.1 Japan Therapeutic Nuclear Medicines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Therapeutic Nuclear Medicines Sales Breakdown by Type (2022-2027)
9.3 Japan Therapeutic Nuclear Medicines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Therapeutic Nuclear Medicines Market Facts & Figures
10.1 Southeast Asia Therapeutic Nuclear Medicines Sales by Company
10.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales by Company (2016-2021)
10.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue by Company (2016-2021)
10.2 Southeast Asia Therapeutic Nuclear Medicines Sales Breakdown by Type
10.2.1 Southeast Asia Therapeutic Nuclear Medicines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Therapeutic Nuclear Medicines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Therapeutic Nuclear Medicines Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Therapeutic Nuclear Medicines Market Facts & Figures
11.1 India Therapeutic Nuclear Medicines Sales by Company
11.1.1 India Therapeutic Nuclear Medicines Sales by Company (2016-2021)
11.1.2 India Therapeutic Nuclear Medicines Revenue by Company (2016-2021)
11.2 India Therapeutic Nuclear Medicines Sales Breakdown by Type
11.2.1 India Therapeutic Nuclear Medicines Sales Breakdown by Type (2016-2021)
11.2.2 India Therapeutic Nuclear Medicines Sales Breakdown by Type (2022-2027)
11.3 India Therapeutic Nuclear Medicines Sales Breakdown by Application
11.3.1 India Therapeutic Nuclear Medicines Sales Breakdown by Application (2016-2021)
11.3.2 India Therapeutic Nuclear Medicines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business
12.1 Novartis AG
12.1.1 Novartis AG Corporation Information
12.1.2 Novartis AG Business Overview
12.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis AG Therapeutic Nuclear Medicines Products Offered
12.1.5 Novartis AG Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Therapeutic Nuclear Medicines Products Offered
12.2.5 Bayer Recent Development
12.3 China Isotope & Radiation
12.3.1 China Isotope & Radiation Corporation Information
12.3.2 China Isotope & Radiation Business Overview
12.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Products Offered
12.3.5 China Isotope & Radiation Recent Development
12.4 Q BioMed
12.4.1 Q BioMed Corporation Information
12.4.2 Q BioMed Business Overview
12.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Q BioMed Therapeutic Nuclear Medicines Products Offered
12.4.5 Q BioMed Recent Development
12.5 Curium Pharmaceuticals
12.5.1 Curium Pharmaceuticals Corporation Information
12.5.2 Curium Pharmaceuticals Business Overview
12.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
12.5.5 Curium Pharmaceuticals Recent Development
12.6 Jubilant DraxImage
12.6.1 Jubilant DraxImage Corporation Information
12.6.2 Jubilant DraxImage Business Overview
12.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Products Offered
12.6.5 Jubilant DraxImage Recent Development
12.7 Dongcheng
12.7.1 Dongcheng Corporation Information
12.7.2 Dongcheng Business Overview
12.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Dongcheng Therapeutic Nuclear Medicines Products Offered
12.7.5 Dongcheng Recent Development
12.8 Lantheus
12.8.1 Lantheus Corporation Information
12.8.2 Lantheus Business Overview
12.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lantheus Therapeutic Nuclear Medicines Products Offered
12.8.5 Lantheus Recent Development
12.9 Acrotech Biopharma.
12.9.1 Acrotech Biopharma. Corporation Information
12.9.2 Acrotech Biopharma. Business Overview
12.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Products Offered
12.9.5 Acrotech Biopharma. Recent Development
12.10 Progenics Pharmaceuticals
12.10.1 Progenics Pharmaceuticals Corporation Information
12.10.2 Progenics Pharmaceuticals Business Overview
12.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
12.10.5 Progenics Pharmaceuticals Recent Development
12.11 International Isotopes
12.11.1 International Isotopes Corporation Information
12.11.2 International Isotopes Business Overview
12.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 International Isotopes Therapeutic Nuclear Medicines Products Offered
12.11.5 International Isotopes Recent Development
13 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
13.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
13.4 Therapeutic Nuclear Medicines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Therapeutic Nuclear Medicines Distributors List
14.3 Therapeutic Nuclear Medicines Customers
15 Market Dynamics
15.1 Therapeutic Nuclear Medicines Market Trends
15.2 Therapeutic Nuclear Medicines Drivers
15.3 Therapeutic Nuclear Medicines Market Challenges
15.4 Therapeutic Nuclear Medicines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Therapeutic Nuclear Medicines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Therapeutic Nuclear Medicines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Therapeutic Nuclear Medicines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Therapeutic Nuclear Medicines Sales (K Units) by Region (2016-2021)
Table 5. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2021)
Table 6. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Therapeutic Nuclear Medicines Revenue Share by Region (2016-2021)
Table 8. Global Therapeutic Nuclear Medicines Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Therapeutic Nuclear Medicines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Therapeutic Nuclear Medicines Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Therapeutic Nuclear Medicines Sales Share by Company (2016-2021)
Table 14. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Therapeutic Nuclear Medicines Revenue Share by Company (2016-2021)
Table 16. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2020)
Table 17. Global Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Therapeutic Nuclear Medicines Manufacturing Sites and Area Served
Table 19. Manufacturers Therapeutic Nuclear Medicines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Therapeutic Nuclear Medicines Sales (K Units) by Type (2016-2021)
Table 22. Global Therapeutic Nuclear Medicines Sales Share by Type (2016-2021)
Table 23. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2016-2021)
Table 25. Global Therapeutic Nuclear Medicines Sales Share by Type (2022-2027)
Table 26. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Therapeutic Nuclear Medicines Revenue Share by Type (2022-2027)
Table 28. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2022-2027)
Table 29. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2016-2021)
Table 30. Global Therapeutic Nuclear Medicines Sales Share by Application (2016-2021)
Table 31. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2016-2021)
Table 33. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2022-2027)
Table 34. Global Therapeutic Nuclear Medicines Sales Share by Application (2022-2027)
Table 35. Global Therapeutic Nuclear Medicines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Therapeutic Nuclear Medicines Revenue Share by Application (2022-2027)
Table 37. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2022-2027)
Table 38. North America Therapeutic Nuclear Medicines Sales (K Units) by Company (2016-2021)
Table 39. North America Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2021)
Table 40. North America Therapeutic Nuclear Medicines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Therapeutic Nuclear Medicines Revenue Market Share by Company (2016-2021)
Table 42. North America Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)
Table 43. North America Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
Table 44. North America Therapeutic Nuclear Medicines Sales by Type (2022-2027) & (K Units)
Table 45. North America Therapeutic Nuclear Medicines Sales Market Share by Type (2022-2027)
Table 46. North America Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)
Table 47. North America Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
Table 48. North America Therapeutic Nuclear Medicines Sales by Application (2022-2027) & (K Units)
Table 49. North America Therapeutic Nuclear Medicines Sales Market Share by Application (2022-2027)
Table 50. Europe Therapeutic Nuclear Medicines Sales (K Units) by Company (2016-2021)
Table 51. Europe Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2021)
Table 52. Europe Therapeutic Nuclear Medicines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Therapeutic Nuclear Medicines Revenue Market Share by Company (2016-2021)
Table 54. Europe Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)
Table 55. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
Table 56. Europe Therapeutic Nuclear Medicines Sales by Type (2022-2027) & (K Units)
Table 57. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2022-2027)
Table 58. Europe Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)
Table 59. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
Table 60. Europe Therapeutic Nuclear Medicines Sales by Application (2022-2027) & (K Units)
Table 61. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2022-2027)
Table 62. China Therapeutic Nuclear Medicines Sales (K Units) by Company (2016-2021)
Table 63. China Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2021)
Table 64. China Therapeutic Nuclear Medicines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Therapeutic Nuclear Medicines Revenue Market Share by Company (2016-2021)
Table 66. China Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)
Table 67. China Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
Table 68. China Therapeutic Nuclear Medicines Sales by Type (2022-2027) & (K Units)
Table 69. China Therapeutic Nuclear Medicines Sales Market Share by Type (2022-2027)
Table 70. China Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)
Table 71. China Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
Table 72. China Therapeutic Nuclear Medicines Sales by Application (2022-2027) & (K Units)
Table 73. China Therapeutic Nuclear Medicines Sales Market Share by Application (2022-2027)
Table 74. Japan Therapeutic Nuclear Medicines Sales (K Units) by Company (2016-2021)
Table 75. Japan Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2021)
Table 76. Japan Therapeutic Nuclear Medicines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Therapeutic Nuclear Medicines Revenue Market Share by Company (2016-2021)
Table 78. Japan Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)
Table 79. Japan Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
Table 80. Japan Therapeutic Nuclear Medicines Sales by Type (2022-2027) & (K Units)
Table 81. Japan Therapeutic Nuclear Medicines Sales Market Share by Type (2022-2027)
Table 82. Japan Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)
Table 83. Japan Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
Table 84. Japan Therapeutic Nuclear Medicines Sales by Application (2022-2027) & (K Units)
Table 85. Japan Therapeutic Nuclear Medicines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Therapeutic Nuclear Medicines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Therapeutic Nuclear Medicines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Therapeutic Nuclear Medicines Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Therapeutic Nuclear Medicines Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application (2022-2027)
Table 98. India Therapeutic Nuclear Medicines Sales (K Units) by Company (2016-2021)
Table 99. India Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2021)
Table 100. India Therapeutic Nuclear Medicines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Therapeutic Nuclear Medicines Revenue Market Share by Company (2016-2021)
Table 102. India Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)
Table 103. India Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
Table 104. India Therapeutic Nuclear Medicines Sales by Type (2022-2027) & (K Units)
Table 105. India Therapeutic Nuclear Medicines Sales Market Share by Type (2022-2027)
Table 106. India Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)
Table 107. India Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
Table 108. India Therapeutic Nuclear Medicines Sales by Application (2022-2027) & (K Units)
Table 109. India Therapeutic Nuclear Medicines Sales Market Share by Application (2022-2027)
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Novartis AG Therapeutic Nuclear Medicines Product
Table 114. Novartis AG Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Bayer Therapeutic Nuclear Medicines Product
Table 119. Bayer Recent Development
Table 120. China Isotope & Radiation Corporation Information
Table 121. China Isotope & Radiation Description and Business Overview
Table 122. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. China Isotope & Radiation Therapeutic Nuclear Medicines Product
Table 124. China Isotope & Radiation Recent Development
Table 125. Q BioMed Corporation Information
Table 126. Q BioMed Description and Business Overview
Table 127. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Q BioMed Therapeutic Nuclear Medicines Product
Table 129. Q BioMed Recent Development
Table 130. Curium Pharmaceuticals Corporation Information
Table 131. Curium Pharmaceuticals Description and Business Overview
Table 132. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product
Table 134. Curium Pharmaceuticals Recent Development
Table 135. Jubilant DraxImage Corporation Information
Table 136. Jubilant DraxImage Description and Business Overview
Table 137. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Jubilant DraxImage Therapeutic Nuclear Medicines Product
Table 139. Jubilant DraxImage Recent Development
Table 140. Dongcheng Corporation Information
Table 141. Dongcheng Description and Business Overview
Table 142. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Dongcheng Therapeutic Nuclear Medicines Product
Table 144. Dongcheng Recent Development
Table 145. Lantheus Corporation Information
Table 146. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Lantheus Description and Business Overview
Table 148. Lantheus Therapeutic Nuclear Medicines Product
Table 149. Lantheus Recent Development
Table 150. Acrotech Biopharma. Corporation Information
Table 151. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Acrotech Biopharma. Description and Business Overview
Table 153. Acrotech Biopharma. Therapeutic Nuclear Medicines Product
Table 154. Acrotech Biopharma. Recent Development
Table 155. Progenics Pharmaceuticals Corporation Information
Table 156. Progenics Pharmaceuticals Description and Business Overview
Table 157. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product
Table 159. Progenics Pharmaceuticals Recent Development
Table 160. International Isotopes Corporation Information
Table 161. International Isotopes Description and Business Overview
Table 162. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. International Isotopes Therapeutic Nuclear Medicines Product
Table 164. International Isotopes Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Therapeutic Nuclear Medicines Distributors List
Table 168. Therapeutic Nuclear Medicines Customers List
Table 169. Therapeutic Nuclear Medicines Market Trends
Table 170. Therapeutic Nuclear Medicines Market Drivers
Table 171. Therapeutic Nuclear Medicines Market Challenges
Table 172. Therapeutic Nuclear Medicines Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Nuclear Medicines Product Picture
Figure 2. Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Therapeutic Nuclear Medicines Sales Market Share by Application in 2021 & 2027
Figure 6. Thyroid Examples
Figure 7. Bone Metastasis Examples
Figure 8. Lymphoma Examples
Figure 9. Other Examples
Figure 10. Global Therapeutic Nuclear Medicines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Therapeutic Nuclear Medicines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Therapeutic Nuclear Medicines Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Therapeutic Nuclear Medicines Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Therapeutic Nuclear Medicines Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Therapeutic Nuclear Medicines Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Therapeutic Nuclear Medicines Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Therapeutic Nuclear Medicines Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Therapeutic Nuclear Medicines Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Therapeutic Nuclear Medicines Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Therapeutic Nuclear Medicines Players Market Share by Revenue in Therapeutic Nuclear Medicines: 2016 & 2020
Figure 29. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Therapeutic Nuclear Medicines Revenue Share by Type (2016-2021)
Figure 31. Global Therapeutic Nuclear Medicines Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Therapeutic Nuclear Medicines Revenue Share by Application (2016-2021)
Figure 33. Global Therapeutic Nuclear Medicines Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Therapeutic Nuclear Medicines Sales Market Share by Type in 2020
Figure 35. North America Therapeutic Nuclear Medicines Sales Market Share by Application in 2020
Figure 36. Europe Therapeutic Nuclear Medicines Sales Market Share by Type in 2020
Figure 37. Europe Therapeutic Nuclear Medicines Sales Market Share by Application in 2020
Figure 38. China Therapeutic Nuclear Medicines Sales Market Share by Type in 2020
Figure 39. China Therapeutic Nuclear Medicines Sales Market Share by Application in 2020
Figure 40. Japan Therapeutic Nuclear Medicines Sales Market Share by Type in 2020
Figure 41. Japan Therapeutic Nuclear Medicines Sales Market Share by Application in 2020
Figure 42. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type in 2020
Figure 43. Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application in 2020
Figure 44. India Therapeutic Nuclear Medicines Sales Market Share by Type in 2020
Figure 45. India Therapeutic Nuclear Medicines Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure 48. Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure 49. Therapeutic Nuclear Medicines Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の核医療治療薬市場規模・現状・予測（2021年-2027年） Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capab…- 世界の核医学治療薬市場規模・現状・予測（2021年-2027年） Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capab…
- 世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- 核医学＆放射性医薬品のグローバル市場調査 2019年 The global Nuclear Medicine & Radio Pharmaceuticals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nuclear Medicine & Radio Pharmaceuticals volume and value at global level, regional level and comp…
- 世界の治療用放射性医薬品市場規模・現状・予測（2021年-2027年） Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capab…